7/1/26 -2.1%
7/1/26 -2.1%
YouTube3 hr 42 min
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Investors should consider Micron (MU) as a high-conviction "buy the dip" opportunity following its recent 7-10% sell-off, which is viewed as an overreaction to broader sector volatility. Meta Platforms (META) is a strong buy for enterprise expansion as it transitions into a cloud provider, a move that could generate $10–$20 billion in new high-margin revenue. Conversely, exercise extreme caution with NVIDIA (NVDA) and specialized cloud providers like Nebius, as Meta’s entry into the chip-rental market signals a potential peak in hardware demand. For aggressive traders, SELLAS Life Sciences (SLS) is a high-conviction short or avoid, as professional short-sellers are paying a massive 150% borrow rate betting on its failure. Long-term investors seeking a "moonshot" should look toward QCLS (QC Technologies) for its 5-year potential to disrupt the industry with photonic computing that scales far beyond current GPU limits.

Detailed Analysis

Meta Platforms (META)

• Meta is reportedly launching its own cloud service to sell excess AI computing capacity and access to its AI models (e.g., Muse, Llama). • Bullish Sentiment: The stock was up significantly (approx. +7% to +10%) following the news. • Strategic Shift: Meta is transitioning from being just a consumer of chips to a provider, potentially generating $10–$20 billion in new revenue from enterprise customers. • Risk/Context: There is debate over whether Meta is renting out "raw" GPUs (bearish for the sector as it implies oversupply) or just providing an API for their models (bullish/neutral).

Takeaways

Monitor Clarifications: Watch for official statements on whether Meta is renting raw compute or just model access. Raw compute rental would be a direct threat to AWS, Azure, and specialized providers like CoreWeave. • Enterprise Expansion: This marks Meta's first real move into the B2B/Enterprise space, which could diversify their revenue away from advertising.


NVIDIA (NVDA)

• The stock saw downward pressure (down approx. 3%) following the Meta news. • Bearish Context: If Meta (one of NVIDIA’s largest customers) has "overbought" chips and is now renting them out, it reduces the need for other companies to buy new chips directly from NVIDIA. • Efficiency Risk: Reports suggest OpenAI may have found ways to lower inference costs by 50%, which could further reduce demand for NVIDIA hardware.

Takeaways

Demand Peak Concerns: The "Meta Cloud" news serves as a potential signal that the "orgy of demand" for GPUs may be reaching a plateau among the largest hyperscalers. • Wait for the Dip: While the long-term AI trend remains, the immediate sentiment is jittery as investors look for signs of a "fever break" in chip demand.


Micron (MU) & Western Digital (WDC/SanDisk)

• Both stocks were hit hard, with Micron down 7-10% and SanDisk down 9%. • Market Sentiment: Despite strong recent earnings, these stocks are being used as "beta" to sell off the AI sector. • Contrarian View: Shkreli noted he is Long Micron, viewing the sell-off as an overreaction and an "indigestion" period for the stock.

Takeaways

Buying Opportunity: If you believe the AI infrastructure build-out isn't over, the 7-10% drop in Micron is highlighted as a potential entry point for a "buy the dip" trade.


SELLAS Life Sciences (SLS)

Strong Bearish Sentiment: Mentioned as a "garbage" stock with a massive 150% borrow rate (the cost to short the stock). • Risk Factor: A high borrow rate indicates extreme conviction from short-sellers. Shkreli warns that retail investors are likely to lose money here. • Clinical Trial Skepticism: Warns that the "healthy patient" bias in trials often leads to failure, despite seemingly positive early data.

Takeaways

Avoid or Short: The recommendation is explicitly to Short SLS or avoid it entirely, citing the professional market's high conviction that the stock will drop.


Bloom Energy (BE)

• The stock showed extreme strength, ripping from $2.90 to $3.20+ despite general market weakness. • Context: Announced a significant deal with Brookfield. • Trading Insight: Shkreli noted he "sold too fast" at $3.15, as the stock continued to show momentum.

Takeaways

Momentum Play: Bloom is currently "decoupled" from the broader tech sell-off due to its specific deal flow. It is viewed as a strong momentum play in the energy/AI infrastructure space.


Photonic Computing & QCLS

Theme: The next frontier beyond electronic transistors. • Investment Opportunity: QCLS (QC Technologies) is mentioned as a "moonshot" play focusing on photonic computers that use light instead of electricity. • Technical Advantage: Photonic computing is significantly better at "matmuls" (matrix multiplication), which is the core of neural networks, and offers a path to 1,000x scaling that traditional GPUs may lack. • Competitors Mentioned: OptiCore, Neurofos, and Luminous.

Takeaways

Long-term Horizon: This is a 5-year moonshot. It is not for short-term traders but for those looking for the "next NVIDIA" in the post-transistor era. • Watch for Patents: The value in this sector lies in proprietary technology that can handle "non-linear functions" entirely in light without converting back to electricity.


Other Notable Mentions

Nebius & CoreWeave: Both down 11-16%. They are viewed as highly vulnerable to Meta's entry into the cloud space. • Palantir (PLTR): Mentioned as a company that enterprises trust for "critical infrastructure" and data control. • Neuralink: Described as "amazing" but currently a niche product for the severely ill, not a "normie" consumer product yet. • Bitcoin (BTC): Struggling to maintain the $60,000 level; sentiment remains cautious. • SpaceX: Noted as a "bumbling firm" in the context of having too many chips and renting them out, similar to Meta.

Ask about this postAnswers are grounded in this post's content.
Video Description
let's get this $
About Martin Shkreli
Martin Shkreli

Martin Shkreli

By @realmartinshkreli

Investing, music, science, math, technology, programming, medicine and more!